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Abstract
Reluctance to talk about corruption is an important barrier to action. Yet the stakes of not addressing corruption 
in the health sector are higher than ever. Corruption includes wrongdoing by individuals, but it is also a problem 
of weak institutions captured by political interests, and underfunded, unreliable administrative systems and 
healthcare delivery models.  We urgently need to focus on corruption as a health systems problem. In addition 
to supporting research to better understand the context and implications of corruption in health systems, this 
article suggests actions that public health professionals can do now to fight corruption.
Keywords: Risk Assessment, Anti-Corruption, Accountability, Transparency
Copyright: © 2019 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Citation: Vian T. High stakes require more than just talk: what to do about corruption in health systems: 
Comment on “We need to talk about corruption in health systems.” Int J Health Policy Manag. 2019;8(8):505–
507. doi:10.15171/ijhpm.2019.33
*Correspondence to:
Taryn Vian
Email: tvian@usfca.edu   
Article History:
Received: 29 April 2019
Accepted: 14 May 2019
ePublished: 2 June 2019
Commentary
School of Nursing and Health Professions, University of San Francisco, San Francisco, CA, USA.
http://ijhpm.com
Int J Health Policy Manag 2019, 8(8), 505–507 doi 10.15171/ijhpm.2019.33
Reluctance to talk about corruption is not new. Hutchinson et al identify five reasons why health policy-makers evade this pervasive problem.1 They 
highlight that corruption is difficult to define, and that what 
is called ‘corruption’ may really reflect coherent — even 
justifiable — actions to cope within severely dysfunctional 
systems. They observe that in documenting corruption 
problems, researchers must sort through incompatible and 
self-serving explanations, and may end up collaborating 
with corrupt officials to retain the access needed to work. 
Development partners may feel that bringing up such 
a sensitive topic might offend or damage relationships 
important to the success of projects. Questions about the 
legitimacy of studying corruption may be another reason 
people are reluctant to discuss the topic. Critics have suggested 
that anti-corruption dialogue is motivated by a neoliberal 
agenda to promote certain forms of social, political, and 
economic organization, not allowing for truly country-led 
development.2,3 Finally, our reticence reflects our chagrin at 
having very few evidence-based practices we can point to as 
solutions.
Robert Klitgaard wrote that the topic of corruption provokes 
evasion, excuses, and surprisingly little analysis.4 Excuses are 
plentiful: “corruption has existed forever,” “corruption greases 
the wheels of development.”5 Debunking excuses is tiresome, 
yet the stakes of not addressing health sector corruption 
are higher than ever. Corrupt countries have higher rates 
of infant, child, and maternal mortality even after adjusting 
for health care spending and other factors.6,7 Corruption in 
the health sector has been linked to higher rates of cancer 
death,8 antimicrobial resistance,9 anxiety,10 and lower patient 
satisfaction with and trust in the healthcare system.11 In 
Ukraine, efforts to fight corruption in procurement systems 
allowed the Ministry of Health to purchase more life-saving 
drugs and medical devices, reducing mortality for heart 
attack patients by 20%.12 Fighting corruption through anti-
corruption measures such as fraud control and inspection, 
and indirectly through health systems strengthening, is a 
goal we must adopt now to save lives. Research is needed to 
determine the most efficient, effective, and feasible approaches 
in specific country contexts.
Though corruption can be tracked to individual leaders 
who put their personal interests above public duty, it is also 
a problem of weak institutions captured by political interests, 
and underfunded, unreliable administrative systems and 
healthcare delivery models.13 We urgently need to focus on 
corruption as a health systems problem. Yet increasing the 
pressure for accountability without dealing with inadequate 
financing can create perverse incentives. The US Veterans 
Administration is a cautionary tale: unrealistic performance 
goals and inadequate funding to reach those goals led 
employees to falsify data and hide performance failures.14
Anti-corruption strategies need to be informed by evidence, 
experience, and context. There is no magic bullet or one “right 
way” to fight corruption in the health sector. Hutchinson et al 
argue for convening key stakeholders to assess risks and reach 
agreement on the nature of the problem, followed by a priority-
setting exercise to determine feasible remedies.1 Klitgaard also 
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recommends participatory diagnosis of problems, noting that 
politicians and officials can be “remarkably forthcoming” in 
workshops, sharing detailed insights on where corruption can 
be found, why it exists, and what can be done to prevent it.5 
Work in Albania found that citizens were not afraid to share 
experiences paying under-the-table for care that should have 
been free.15 Other research has suggested methods to reduce 
reticence of medical professionals in sharing information 
about accepting gifts and informal payments.16,17
Hutchinson et al recommend that researchers and policy-
makers adopt a multi-disciplinary perspective when gathering 
and evaluating evidence of anti-corruption strategies, 
remarking that many pathways for research exist.1 While this 
is true, the time is ripe for convergence on methodologies 
to measure some problems, such as absenteeism, informal 
payments, and insurance fraud. Considering informal 
payments, for example, few studies have tried to separate 
the burdens posed by different types of payments such as 
cash payments, “bought and brought” supplies, and gifts.18 
Rates may also vary due to methodological differences in 
recall periods, or the setting in which a payment was made 
(inpatient versus ambulatory care). Developing common 
indicators and survey research methodologies to allow cross-
national comparison of the scope and nature of this and other 
problems will help us to evaluate whether health reforms are 
having the desired impact.
In 2015, former US President Barak Obama said, “We’re on 
this planet a pretty short time, so that we cannot remake the 
world entirely during this little stretch that we have. But I think 
our decisions matter….[A]t the end of the day, we’re part of a 
long-running story. We just try to get our paragraph right.”19 
President Obama was aware that we inherit a world with 
“grudges, rivalries, hatreds, and sins of the past,” and there are 
limits to what we can fix and make better. Yet, there are things 
we can do, and this applies to seemingly intractable problems 
like corruption. We are part of a longer story, our decisions 
matter, and we need to work on getting our paragraph right. 
So, here are five things that public health professionals can do 
now to fight corruption.
1. Adopt an ethical frame when making decisions. Behavioral 
economists and business ethicists have studied how social 
norms and informal values exert a strong influence on people’s 
behavior, and how we frame problems influences how people 
think.20 Health leaders should stop to consider whether ethical 
principles are at stake when making decisions, especially in 
designing changes to administrative systems. Small signals, 
such as where and when we sign a form, can have an impact 
in promoting integrity.21
2. Assess risks of corruption. Health professionals who are 
part of a team starting a new project or program should ask 
about whether the staff are getting adequate training to assure 
that staff interests are aligned with the project’s goals. It is 
important to ask about oversight procedures, and checks and 
balances to assure that people are able to resist temptation to 
engage in wrongdoing. Minimizing occupational temptation 
helps everyone.22
3. Strengthen accountability in programs. Health professionals 
should understand the accountability structures in their 
programs. Who is accountable to whom, for what, and ‘so what’ 
(eg, what are the consequences for failures in accountability)? 
Start a discussion of ways to create fairer processes and to 
reward good performance or identify and address performance 
that is not up to standard. Suggest activities that will bring 
the people in power into closer touch with those people who 
depend on their decisions (lower level staff, constituencies).23
4. Value and model transparency. Health professionals at all 
levels of an organization can encourage active internal and 
external transparency and information sharing. According 
to the Association of Certified Fraud Examiners, the most 
effective measures for fraud control include proactive data 
monitoring and analysis, management review of accounts 
and transactions, and hotlines (each producing 50%-54% 
reduction in median losses).24 For a team leader, this may 
just involve telling your team members what to do if they are 
not paid on time, or they see something that seems unfair or 
not right. Do not assume people know how to complain. In 
programs with formal complaint hotlines, it is important to 
test the hotline periodically to be sure it is working. Health 
research should experiment with methods to adapt complaint 
mechanisms successfully to different local contexts.
5. Support and involve civil society organizations in your work. 
Health professionals should encourage partnerships with 
community-based organizations that are trying to empower 
citizens, whether they currently work in the health sector or 
not. The health sector is complicated, and corrupt actors take 
advantage of this complexity to hide their malfeasance. Help 
anti-corruption non-governmental organizations to become 
more knowledgeable about health issues. The more citizens, 
community-based organizations, and non-governmental 
organizations know about how the sector is organized and 
financed, the more easily they can identify and call attention 
to corruption risks.
While it may still be uncomfortable to talk about corruption, 
we must have these difficult conversations and move beyond 
them to action. We need to foster opportunities to discuss 
problems together, to build on-the-ground knowledge. 
Corruption is a social determinant of health. It is a cost 
that rarely is quantified in our cost-effectiveness analyses, a 
risk often is not mentioned in project appraisal reports. Yet, 
corruption is a real barrier preventing us from achieving our 
goals in public health. We need to work harder to understand 
why corruption happens, and to take actions — as health and 
development professionals, as government officials, and as 
citizens — to prevent it.
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